24
Feb
2009
Posted in I - Series C, Q - 1Q09, R - WEST, X - Aesthetics, X - Dermatology, XX - CA
Kythera Biopharmaceuticals (Calabasas, CA) a clinical-stage biopharmaceutical company focused on aesthetic dermatology, closed a $10M Sereis C financing, bringing the total round to $40M. Participants include Versant Ventures, ARCH Venture Partners, Prospect Venture Partners, BBT Capital Management, JAFCO Ventures and Altitude Life Science Ventures.